M&A Deal Summary

DSM-Firmenich Acquires Roche Vitamins and Fine Chemicals

On January 21, 2014, DSM-Firmenich acquired consumer products company Roche Vitamins and Fine Chemicals from F. Hoffmann-La Roche

Acquisition Highlights
  • This is DSM-Firmenich’s 2nd transaction in the Consumer Products sector.
  • This is DSM-Firmenich’s 1st transaction in Switzerland.

M&A Deal Summary

Date 2014-01-21
Target Roche Vitamins and Fine Chemicals
Sector Consumer Products
Buyer(s) DSM-Firmenich
Sellers(s) F. Hoffmann-La Roche
Deal Type Divestiture

Target

Roche Vitamins and Fine Chemicals

Kaiseraugst, Switzerland
Roche Vitamins and Fine Chemicals is a producer of vitamins, carotenoids, nutritional lipids, enzymes and other healthy ingredients for human and animal nutrition.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

DSM-Firmenich

Kaiseraugst, Switzerland

Category Company
Founded 1902
Sector Chemicals
Employees26,301
Revenue 12.8B EUR (2024)
DESCRIPTION

DSM-Firmenich specializes in the development, manufacture, and marketing of performance materials, nutritional and pharmaceutical ingredients, and industrial chemicals. The products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing, and electrics & electronics. DSM-Firmenich was founded in 1902 and is based in Kaiseraugst, Switzerland.


DEAL STATS #
Overall 21 of 28
Sector: Consumer Products M&A 2 of 4
Type: Divestiture M&A Deals 4 of 5
Country: Switzerland M&A 1 of 2
Year: 2014 M&A 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-11-19 Patheon BV

Durham, North Carolina, United States

Patheon BV is a global provider of pharmaceutical development and manufacturing services. With approximately 9,000 professionals worldwide, Patheon provides a comprehensive, integrated and highly customizable set of solutions to help clients of all sizes satisfy complex development and manufacturing needs at any stage of the pharmaceutical development cycle. A Healthier World. Delivered.

Buy $2.6B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-03-11 DPx Holdings BV

Framingham, Massachusetts, United States

DPx Holdings BV is a provider of development and manufacturing services, pharmaceutical products and technologies and select chemical products for other industries. DPx Holdings was founded in 2014 and is based in Framingham, Massachusetts.

Buy $2.7B

Seller(S) 1

SELLER

F. Hoffmann-La Roche

Basel,, Switzerland

Category Company
Founded 1896
Sector Life Science
DESCRIPTION

F. Hoffmann-La Roche Ltd. is a provider of in-vitro diagnostics and drugs for cancer and transplantation


DEAL STATS #
Overall 1 of 1
Sector: Consumer Products M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: Switzerland M&A 1 of 1
Year: 2014 M&A 1 of 1